TITLE

Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD 15 3020insC mutation?

AUTHOR(S)
Buhner, S.; Buning, C.; Genschel, J.; Kling, K.; Herrmann, D.; Dignass, A.; Kuechler, I.; Krueger, S.; Schmidt, H. H.-J.; Lochs, H.
PUB. DATE
March 2006
SOURCE
Gut;Mar2006, Vol. 55 Issue 3, p342
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aim: A genetically impaired intestinal barrier function has long been suspected to be a predisposing factor for Crohn's disease (CD). Recently, mutations of the capsase recruitment domain family, member 15 (CARD15) gene have been identified and associated with CD. We hypothesise that a CARD15 mutation may be associated with an impaired intestinal barrier. Methods: We studied 128 patients with quiescent CD, 129 first degree relatives (CD-R), 66 non-related household members (CD-NR), and 96 healthy controls. The three most common CARD15 polymorphisms (R702W, G908R, and 3020insC) were analysed and intestinal permeability was determined by the lactulose/mannitol ratio. Results: Intestinal permeability was significantly increased in CD and CD-R groups compared with CD-NR and controls. Values above the normal range were seen in 44% of CD and 26% of CD-R but only in 6% of CD-NR, and in none of the controls. A household community with CD patients, representing a common environment, was not associated with increased intestinal permeability in family members. However, 40% of CD first degree relatives carrying a CARD15 3020insC mutation and 75% (3/4) of those CD-R with combined 3020insC and RTO2W mutations had increased intestinal permeability compared with only 15% of wild-types, indicating a genetic influence on barrier function. R702W and G908R mutations were not associated with high permeability. Conclusions: In healthy first degree relatives, high mucosal permeability is associated with the presence of a CARD15 3020insC mutation. This indicates that genetic factors may be involved in impairment of intestinal barrier function in families with IBD.
ACCESSION #
20098085

 

Related Articles

  • NOD takes its toll but stays in the CARDs in Crohn’s disease. Luft, Friedrich // Journal of Molecular Medicine;Aug2005, Vol. 83 Issue 8, p577 

    Points out to the growing body of evidence implicating nucleotide-binding oligomerization domain (NOD) 2 and toll-like receptor (TLR) 4 mutations in Crohn's disease. Occurrence of inflammatory bowel diseases in areas of the gastrointestinal tract with the highest numbers of luminal bacteria;...

  • REGIONAL ENTERITIS. Berger, Samuel S. // American Journal of Gastroenterology;Jul1956, Vol. 26 Issue 1, p81 

    Presents a case of a patient with regional enteritis. Persistence of abdominal pains suffered by the patient; Examination of the abdomen of the patient; Pathology of the regional enteritis.

  • Small bowel length in Crohn's disease. Glehen, O.; Lifante, J. C.; Vignal, J.; Francois, Y.; Gilly, F. N.; Flourié, B.; Descos, L.; Chung, R. J. H.; Mithieux, F. // International Journal of Colorectal Disease;Sep2003, Vol. 18 Issue 5, p423 

    Background and aims. This prospective study compared jejunoileal length in patients with Crohn's disease (CD) and the general population to determine whether this parameter can be related to outcome and management of CD complications. Patients and methods. Small bowel (SB) length was measured...

  • Granulomatous Enterocolitis Complicated by Osteomyelitis. Meltzer, Saul S. // American Journal of Gastroenterology;Jan1973, Vol. 59 Issue 1, p77 

    Osteomyelitis complicating granulomatous disease of the bowel is described in a case report. Bony complications of this disorder should be kept in mind since they may occur more commonly than has previously been appreciated.

  • A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Ogura, Yasunori; Bonen, Denise K.; Inohara, Naohiro; Nicolae, Dan L.; Chen, Felicia F.; Ramos, Richard; Britton, Heidi; Moran, Thomas; Karaliuskas, Reda; Duerr, Richard H.; Achkar, Jean-Paul; Brant, Steven R.; Bayless, Theodore M.; Kirschner, Barbara S.; Hanauer, Stephen B.; Nunez, Gabriel; Cho, Judy H. // Nature;5/31/2001, Vol. 411 Issue 6837, p603 

    Presents a study which determined the association of a frameshift mutation in NOD2 caused by a cytosine insertion with Crohn's disease. Background on the idiopathic inflammatory bowel diseases; Methods used; Findings of the study.

  • MULTIFACTORIAL DISEASE: Opening the flood gates? Alfred, Jane // Nature Reviews Genetics;Jul2001, Vol. 2 Issue 7, p486 

    Deals with two studies which identified linkage mapping of NOD2, a gene involved in Crohn disease (CD). Way by which the immune system might be involved in the etiology of CD; Association of CD to an allele of a chromosome 16 microsatellite marker; Mutations in the leucine-rich repeat region of...

  • Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn’s disease patients. Braat, Henri; Stokkers, Pieter; Hommes, Tijmen; Cohn, Danny; Vogels, Esther; Pronk, Inge; Spek, Arnold; Kampen, Antoine; Deventer, Sander; Peppelenbosch, Maikel; Hommes, Daan // Journal of Molecular Medicine;Aug2005, Vol. 83 Issue 8, p601 

    The concept that mutations in germ-line encoded pattern recognition receptors with immune activating functions are associated with an increased incidence in Crohn’s disease (CD) is gaining acceptance. Whether these mutations have similar or distinct effects on cellular physiology remains...

  • Endoscopic Management of Inflammatory Bowel Disease. Modigliani, Robert // American Journal of Gastroenterology;Aug1994 Supplement, Vol. 89 Issue 8, pS53 

    Discusses the role of endoscopy in inflammatory bowel disease. Discussion on the basic endoscopic lesions on inflammatory bowel disease; Definition of the nature of stricture and mass lesions; Evaluation of patients with cholestasis; Analysis of endoscopic treatment of intestinal strictures in...

  • Advances in the Inflammatory Bowel Diseases.  // Gut;Jul2004, Vol. 53 Issue 7, p1058 

    The article presents that the conference for advances in the inflammatory bowel diseases will be held in Chicago, Illinois, from October 8-9, 2004.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics